title: PAR1 antagonist mediated antithrombotic activity in extracorporeal arterio-venous shunt in the rat.
authors.affiliation: Centre de Recherche Pierre Fabre, 17 Av. Jean Moulin, 81106 Castres Cedex, France. robert.letienne@pierre-fabre.com
authors.forename: Robert
authors.initials: R
authors.lastname: Létienne
authors.forename: Anne
authors.initials: A
authors.lastname: Leparq-Panissié
authors.forename: Arnaud
authors.initials: A
authors.lastname: Bocquet
authors.forename: Yannick
authors.initials: Y
authors.lastname: Calmettes
authors.forename: Charlène
authors.initials: C
authors.lastname: Culié
authors.forename: Bruno
authors.initials: B
authors.lastname: Le Grand
mesh_terms: D000818:Animals; D001166:Arteriovenous Shunt, Surgical / Q000379:methods; D005343:Fibrinolytic Agents / Q000378:metabolism*; D054833:Isoindoles / Q000037:antagonists & inhibitors; D008297:Male; D011758:Pyrroles / Q000037:antagonists & inhibitors; D011799:Quinazolines / Q000037:antagonists & inhibitors; D051381:Rats; D011919:Rats, Inbred Strains; D010975:Platelet Aggregation Inhibitors
chemical_list: C550447:ER 121958; D005343:Fibrinolytic Agents; D054833:Isoindoles; C415424:N3-cyclopropyl-7-((4-(1-methylethyl)phenyl)methyl)-7H-pyrrolo(3, 2-f)quinazoline-1,3-diamine; D011758:Pyrroles; D011799:Quinazolines; D010975:Platelet Aggregation Inhibitors